PARP1 and head and neck squamous cell carcinoma: Indeed, functional defects in DNA crosslink repair have been observed in a significant proportion of HNSCC cell lines, in terms of MMC-hypersensitivity, G2-blockade, and olaparib (PARP-inhibitor) hypersensitivity [138].